Molecular techniques (PCR and RFLP) were used to verify the presence of Panax ginseng C.A. Meyer in commercial products containing ginseng. DNA, extracted from four vegetable forms present in marketed products, was amplified with 18df/28ccr primers. The RFLP of the DNA amplified products, obtained using Inf I, Sau 3A1 and Taq I endonucleases, allowed the identification of P. ginseng and its differentiation from P. quinquefolium. P. ginseng was detected in 9 out 16 samples tested which, according to the declaration on the labels, contained the drug. Negative results were obtained for products containing the dried extract of the drug. A comparison of the results acquired using the molecular techniques with those using HPLC is also reported.
Molecular biology constitutes a new frontier for phytochemical analysis, allowing the improvement of previous knowledge, as well as the acquisition of new data. Recently, molecular techniques have been successfully utilised in order to validate plant drugs, overcoming the limitations of traditional analyses [1] [2] [3] [4] . In the present study, PCR and RFLP were used in order to authenticate Panax ginseng C.A. Meyer (Korean ginseng) in different vegetable forms of ginseng commercial products and to differentiate it from other Panax species and from some of their adulterants. A comparison with HPLC identification results was also made.
There is an ongoing question over the labelling of herbal products as "Ginseng". Currently the word "Ginseng" is used to sell a variety of herbs associated with certain claimed therapeutic properties (Table 1) . This can be confusing as they neither contain the ____________ + Part 1 in the Series: "Molecular identification of herbal drugs" same constituents nor display the same biochemical properties.
The quality of ginseng commercial products influences their effectiveness and safety of use and depends on the employed raw materials. The most active constituents of P. ginseng are steroidal saponins, called ginsenosides. So far 22 ginsenosides have been isolated and characterised, based on triterpene aglycone moieties with dammarane and oleanane structures and on the sugar unit sequences. In the monograph entitled "Ginseng" [5] the European Pharmacopoeia (Ph. Eur.) reports only the whole or cut dried root of P. ginseng, that must contain ginsenoside Rf and not less than 0.40% of combined ginsenosides Rg1 and Rb1, calculated with reference to the dried drug. This is, therefore, the only true ginseng (Korean ginseng).
Since the 1990s differentiation and research on the various species of Panax have been reported and the [6] [7] [8] [9] . However, as reported in the Ph. Eur. [5] , TLC and HPLC are the official tools to detect the presence of ginsenosides in root commercial samples. These methods need time (two working days), and a large quantity of plant material, as well as reference standards, that are often difficult to obtain. The objective of the present study was to develop and standardise a reliable and easy molecular method for authentication of P. ginseng in the different forms of commercial ginseng products and to compare these results with HPLC identification made on the same samples [10] .
NPC Natural Product Communications
Useful amounts of DNA were extracted from all the considered samples (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . PCR amplification was made using 18df/28ccr primers. The DNA amplified products, digested with the endonucleases Hinf I, Taq I and Sau 3A1, gave fragments of 170 bp; 230 bp and 280 bp; and 120 bp and 580 bp, respectively, characteristic for P. ginseng. Similarly, fragments of 60 bp and 100 bp; and 106 bp, 170 bp and 260 bp, were obtained for P. quinquefolium (American ginseng) with the use of Hinf I and Taq I, respectively (Figure 1 ). For a total of 486 determinations (19 samples, 3 repetitions, 3 extraction protocols, following PCR and restriction with 3 endonucleases), the molecular analysis confirmed the presence of Panax species in 12 out of 19 samples tested, as shown in Table 2 . Three of the positive samples, named PQ, PQT, PQP (6, 11, 12), were commercial ginseng products containing P. quinquefolium in the form of dried body root, dried root tails and dried root prongs, respectively. Among the samples labelled PG (1-5,  7-10, 13-19) , the presence of P. ginseng was confirmed, as reported on the label, in 9 out of 16 samples, but not in three dried body root products (4, 5, 18) or in four dried extract samples (15-17, 19) . The presence of adulterants such as Mirabilis jalapa L. and Phytolacca acinosa Roxb could be excluded in the considered samples since no specific Sau 3A1 digestion fragments [11] for either plant were visualised in agarose gel. HPLC analysis [10] , conducted as reported in the Ph. Eur. [5] , revealed the presence of all ginsenosides used as reference standards. As required by the Ph. Eur. monograph [5] , ginsenosides Rg1 and Rb1 were identified in all tested samples and Rf, characteristic of P. ginseng, was detected in only 9 out of the 16 PG samples, which claimed to be based on P. ginseng. In particular, ginsenoside Rf was absent from the three PQ samples (6, 11, 12), as expected for P. quinquefolium products, and from seven PG samples (4, 5, 8, 13, 15, 16, 18 ).
Molecular identification of
The PCR and RFLP results were in accordance with the HPLC data (presence of ginsenoside Rf, characteristic of P. ginseng) for the majority of the tested commercial products and in accordance with the species, P. ginseng, declared on their labels. PCR and RFLP/HPLC afforded negative results for five products, in the form of dried body root (4, 5, 18) and of dried extract (15, 16) , which excluded the presence of P. ginseng, although this was declared on the label. On the other hand, discordance between the molecular results and HPLC data was noted when the preparation was based on dried extracts (17, 19).
Molecular methods have been used to unequivocally allow the authentication to species level of the genus Panax and the results were not affected by the nature of the drug. Compared with other methods that detect genome-wise polymorphism simultaneously, such RAPD [12] , AP-PCR and AFLP [13] , the method applied in this research, based on PCR followed by RFLP, is more reliable for large scale screening of commercial products, is rapid (one working day), and the results are easily readable. However, the procedure failed when the commercial products were dried extracts. A sample of reference P. ginseng was processed as described in the European Pharmacopoeia monograph [5] , by boiling the root powder in 50% (v/v) aqueous methanol for 1h, to obtain a dried extract (19). This prepared extract resulted in a negative result in the molecular analytical procedure, as expected, because DNA molecules are not soluble in the hydromethanolic solvent, whereas the extract gave a positive for Rf on HPLC examination.
Experimental
The analysed commercial ginseng products as raw materials in the form of body root, root tails and root prongs, and as capsules and tablets containing also dried extract were obtained from national health care stores. To protect the Manufacturers' identities the sample sources were labelled as reported in Table 2 .
An AB GeneAmp PCR System 9700 thermal cycler was used for the PCR analysis. P. ginseng and P. quinquefolium dried roots, used as references for the molecular analysis, were kindly provided by the Department of Plant Biology of the University of La Sapienza, Rome, Italy. Chromatography was performed on a Waters chromatographic system equipped with a Waters 600 MS multisolvent delivery system and a Waters 717 Auto sampler. A Waters 996 Photodiode Array Detector was used to monitor the eluates at 203 nm. The chromatographic data were analysed using a Waters Millennium Software version 3.2. Chromatography was performed at room temperature (25° C). Ginsenosides Rg1, Rb1, Rb2, and Rc−Rf, purchased from Extrasynthese, France, were used as reference standards.
Molecular analysis: DNA was extracted from 50-100 mg of each sample using an Invitrogen Easy-DNA Kit [14] and two other molecular protocols [15, 16] Chemical analysis: Analysis of the principal active constituents was performed on all available samples by the HPLC method described in the "Ginseng" monograph of the Ph. Eur. [5] , using a 5 μm (25 cm x 4.6 mm) Kromasil KR100-5NH2 E6170 column, a mobile phase filtered on an Alltech nylon membrane 47 mm, 0.45 μm, and degassed by a Waters in line degasser, at a flow rate of 1 mL/min.
